WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed), the Association of periOperative Registered Nurses (AORN), and the American Hospital Association (AHA) today released “Re-entry Guidance for Health Care Facilities and Medical Device Representatives.” As health care professionals and organizations consider when and how to safely resume elective surgeries paused during the COVID-19 pandemic, this guidance adds principles and considerations to support the vital collaboration between health care personnel and medical device representatives.
AdvaMed Joins AORN, AHA in Issuing “Re-entry Guidance for Health Care Facilities and Medical Device Representatives”
Press Release | May 19, 2020
Blog Post | May 11, 2020
Behind the scenes, the medical technology industry is working around-the-clock to manufacture the critical supplies providers need to combat the coronavirus. Across the country, manufacturers are adding shifts, ramping up alternative production lines and working overtime to produce personal protective equipment (PPE), ventilators and the diagnostic tests desperately needed on the front lines.
Press Release | May 8, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced availability of a newly created “Code of Ethics Compliance Guidance Related to the COVID-19 Response.”
May 29, 2020 |
12:00pm-1:00pm ET Clinicians assume diagnostic tests are accurate, reliable and clinically valid. IVD products require evidence that the test accurately takes a measurement and the risk of false or... Read More
October 5, 2020 to October 7, 2020| Toronto, Canada
From October 5–7, 2020, more than 3,300 of the world's top medtech executives will gather in Toronto, Ontario for the leading event in our industry – The MedTech Conference. Featuring world‑... Read More
October 27, 2020 to October 28, 2020| Washington, DC
Whether you have recently taken on compliance responsibilities, are about to set up a new compliance structure, are in the midst of revamping your existing program, or you simply need a refresher,... Read More
October 28, 2020 to October 29, 2020| Washington, DC
If you manage health care compliance in a medical device company, you know the complex nature of your work, and that absolute issue resolutions can be elusive. This advanced program will tackle some... Read More
Scott Whitaker, President & CEO of Advamed, returns to "The Other Side" with Joe Mullings to share updates on how AdvaMed and other organizations are helping to navigate medtech companies in response to policy updates from the FDA and Washington.
BOTHELL, Wash., May 20, 2020 /PRNewswire/ -- FUJIFILM Sonosite, Inc., the world leader in point-of-care ultrasound, has announced Rich Fabian, the company's President and Chief Operating Officer, was appointed to the board of The Advanced Medical Technology Association (AdvaMed), a Washington D.C.-based trade association that leads the effort to advance medical technology in order to achieve healthier lives and healthier economies around the world.
Martinez, CA, USA – March 26, 2020 – Treatment of COVID-19 with ExThera’s Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) has begun in hospitals in Germany and Italy. Seraph 100 treatments of COVID-19 are also expected to begin soon in France and the USA. Seraph 100 is the only ‘hemoperfusion device’ approved for the reduction of pathogens in blood. In recent EU clinical cases improved lung function and rapid reduction of drug-resistant bacterial pathogens occurred with Seraph 100...
HAYWARD, Calif.--RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT)* to treat all stages of cancer today announced it has received marketing clearance from the U.S. Food & Drug Administration (FDA) for stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT) for its RefleXion™ X1 machine. “We are at the forefront of an enormous change in expanding the use of radiotherapy from a...
BOSTON and SYDNEY — 28 January 2020 — GI Dynamics® Inc. (ASX:GID), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce the first patient in the United States (U.S.) STEP-1 clinical trial has been enrolled at Michigan Medicine in Ann Arbor, Michigan. Michigan Medicine is one of five clinical study sites for the STEP-1 trial; the site is led by principal investigator Allison R. Schulman M.D., M.P.H., assistant professor of...
SAN JOSE, Calif., December 3, 2019 — Venclose Inc., a privately-held Silicon Valley medical device company focused on innovative treatment procedures for venous reflux disease today announced it has closed a Series C funding led by Ally Bridge Group (ABG). ABG is a global life science-focused group with a successful investment record globally in supporting high-growth innovative life science companies. “Securing this financing further confirms continued investor confidence in Venclose’s...
May 25, 2020 - 11:26am